Latest filing published 15 May 2018 for Co-Diagnostics, Inc., €1,993.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -45.0%Entry US$51.00 · Close at T+365 US$28.05
- -45.1%Entry US$55.20 · Close at T+365 US$30.30
- -45.7%Entry US$56.40 · Close at T+365 US$30.60
- -47.7%Entry US$58.50 · Close at T+365 US$30.60
- -43.6%Entry US$57.00 · Close at T+365 US$32.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Brent Satterfield: trading record in brief
Brent Satterfield appears in our data through filings on Co-Diagnostics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 9 April 2018 to 11 May 2018, the count stands at 6 filings.
On the market, this insider has only ever bought: 6 purchases, €12k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €1,410 and half below. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days. Ninety days after publication, 5 purchases show a median change of +91.1%, with the price up in 100% of them. They describe history only and say nothing certain about the share price ahead.
Most recently, on 15 May 2018, the filings show an open-market purchase worth €1,993 in Co-Diagnostics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Brent Satterfield
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,305 shares@ US$1.8223.7% of flowCommon StockSEC:0001493152-18-006942:0Canonical exit: 9 Aug 2018 (T+90)
- 500 shares@ US$1.919.5% of flowCommon StockSEC:0001493152-18-006315:0Canonical exit: 1 Aug 2018 (T+90)
- 500 shares@ US$2.029.9% of flowCommon StockSEC:0001493152-18-005684:0Canonical exit: 22 Jul 2018 (T+90)
- 500 shares@ US$1.949.3% of flowCommon StockSEC:0001493152-18-005251:0Canonical exit: 15 Jul 2018 (T+90)
- 2,400 shares@ US$2.0547.6% of flowCommon StockSEC:0001493152-18-005004:0Canonical exit: 8 Jul 2018 (T+90)
5 of 5 declarations